HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Moon-Chang Baek Selected Research

biapenem (L 627)

6/2021Biapenem reduces sepsis mortality via barrier protective pathways against HMGB1-mediated septic responses.
2/2020Biapenem as a Novel Insight into Drug Repositioning against Particulate Matter-Induced Lung Injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Moon-Chang Baek Research Topics

Disease

17Neoplasms (Cancer)
01/2022 - 10/2009
10Inflammation (Inflammations)
01/2022 - 01/2012
8Breast Neoplasms (Breast Cancer)
01/2022 - 10/2012
8Sepsis (Septicemia)
06/2021 - 04/2016
6Lung Injury
02/2020 - 04/2016
6Hypothermia
01/2019 - 08/2012
5Anaphylaxis (Anaphylactic Shock)
01/2019 - 01/2017
3Insulin Resistance
12/2015 - 07/2013
3Type 2 Diabetes Mellitus (MODY)
06/2015 - 09/2012
2Bone Resorption
08/2021 - 02/2021
2Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2016
2Infections
02/2020 - 01/2003
2Colonic Neoplasms (Colon Cancer)
11/2018 - 09/2014
2Neoplasm Metastasis (Metastasis)
03/2017 - 01/2016
2Septic Shock (Toxic Shock Syndrome)
01/2017 - 04/2016
2Neuroinflammatory Diseases
09/2014 - 08/2012
2Brain Injuries (Brain Injury)
12/2012 - 08/2012
2Carcinoma (Carcinomatosis)
10/2012 - 10/2009
2Virus Diseases (Viral Diseases)
06/2004 - 01/2003
1Colitis
01/2022
1Endotoxemia
08/2021
1Alcoholic Fatty Liver
08/2021
1Dysbiosis
08/2021
1Bone Diseases (Bone Disease)
08/2021
1Osteoporosis
08/2021
1Alveolar Bone Loss
02/2021
1Fibrosarcoma
02/2021
1Periodontitis
02/2021
1Blindness (Hysterical Blindness)
01/2021
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2021
1Retinal Neovascularization
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Macular Degeneration (Age-Related Maculopathy)
01/2021

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
08/2021 - 07/2010
11Biomarkers (Surrogate Marker)IBA
12/2021 - 06/2011
10Pharmaceutical PreparationsIBA
01/2022 - 01/2012
7HMGB1 Protein (HMG1)IBA
06/2021 - 04/2016
6Immunoglobulin E (IgE)IBA
01/2019 - 01/2016
5CytokinesIBA
01/2022 - 01/2016
5OvalbuminIBA
01/2019 - 01/2017
4Peptides (Polypeptides)IBA
11/2021 - 12/2010
4EnzymesIBA
06/2016 - 06/2004
3Biological ProductsIBA
01/2022 - 08/2012
3AntioxidantsIBA
01/2022 - 10/2019
3Sulfisoxazole (Sulfafurazole)FDA Link
01/2022 - 09/2016
3Particulate MatterIBA
02/2020 - 01/2019
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 09/2012
3Interleukin-4 (Interleukin 4)IBA
01/2019 - 10/2017
3Histamine (Histamine Dihydrochloride)FDA Link
01/2019 - 01/2017
3MethylthiouracilIBA
01/2017 - 09/2015
3ProteomeIBA
09/2014 - 08/2012
3Fatty Acids (Saturated Fatty Acids)IBA
03/2014 - 01/2012
2Endothelin Receptors (Endothelin Receptor)IBA
01/2022 - 01/2019
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2022
2Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
11/2021 - 10/2017
2Local Anti-Infective Agents (Antiseptics)IBA
06/2021 - 01/2019
2biapenem (L 627)IBA
06/2021 - 02/2020
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2021 - 03/2014
2Mitogen-Activated Protein KinasesIBA
02/2021 - 03/2014
2Peroxidase (Myeloperoxidase)IBA
02/2020 - 01/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 10/2019
2Interleukin-6 (Interleukin 6)IBA
10/2019 - 12/2016
2decursinIBA
01/2019 - 01/2019
2Acetaminophen (Paracetamol)FDA LinkGeneric
10/2018 - 01/2017
2Cisplatin (Platino)FDA LinkGeneric
07/2017 - 01/2012
2Immunoglobulin G (IgG)IBA
01/2017 - 01/2016
2Antithyroid Agents (Antithyroid Drugs)IBA
12/2016 - 09/2015
2Tumor Biomarkers (Tumor Markers)IBA
06/2016 - 01/2016
2N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime (PUGNAC)IBA
12/2015 - 10/2013
2Matrix Metalloproteinases (MMPs)IBA
09/2014 - 07/2010
2Messenger RNA (mRNA)IBA
09/2014 - 10/2011
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
03/2014 - 04/2013
2XenobioticsIBA
03/2014 - 04/2013
2Glucose (Dextrose)FDA LinkGeneric
07/2013 - 12/2011
2Urea (Carbamide)FDA LinkGeneric
04/2013 - 01/2012
1Chimeric Antigen ReceptorsIBA
01/2022
1Cancer VaccinesIBA
01/2022
1SulfonamidesIBA
01/2022
1formycin diphosphate (FDP)IBA
01/2022
1macitentanIBA
01/2022
1B7-H1 AntigenIBA
01/2022
1Dextran SulfateIBA
01/2022
1Ellagic AcidIBA
08/2021
1Ciclopirox (Loprox)FDA LinkGeneric
08/2021
1Collagen Type I (Type I Collagen)IBA
08/2021
1OsteocalcinIBA
08/2021
1fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
02/2021
1PF 3845IBA
02/2021
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2021
1RANK LigandIBA
02/2021
1Oxygen (Dioxygen)IBA
01/2021
1InterferonsIBA
01/2021

Therapy/Procedure

6Therapeutics
01/2022 - 09/2015
4Ligation
06/2021 - 01/2019
3Punctures
06/2021 - 01/2019
3Oral Administration
01/2019 - 01/2016
3Drug Therapy (Chemotherapy)
10/2017 - 12/2010
2Immunotherapy
11/2021 - 09/2012
2Induced Hypothermia
12/2012 - 08/2012
1Ovariectomy (Oophorectomy)
08/2021